This is not the most recent version of the article. View current version (5 APR 2016)

Intervention Protocol

You have free access to this content

Chlorpromazine versus atypical antipsychotic drugs for schizophrenia

  1. Kumar B Saha1,*,
  2. Stephanie Sampson2,
  3. Rashid U Zaman3

Editorial Group: Cochrane Schizophrenia Group

Published Online: 3 JUL 2013

DOI: 10.1002/14651858.CD010631


How to Cite

Saha KB, Sampson S, Zaman RU. Chlorpromazine versus atypical antipsychotic drugs for schizophrenia (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 7. Art. No.: CD010631. DOI: 10.1002/14651858.CD010631.

Author Information

  1. 1

    Leeds Partnership NHS Foundation Trust, Forensic Psychiatry, Leeds, UK

  2. 2

    The University of Nottingham, Cochrane Schizophrenia Group, Nottingham, UK

  3. 3

    Oxford Policy Management, Health Portfolio, Oxford, UK

*Kumar B Saha, Forensic Psychiatry, Leeds Partnership NHS Foundation Trust, Forensic Services, Newsam Centre, Seacroft Hospital, York Road, Leeds, LS14 6WB, UK. kbiswajits@yahoo.com.

Publication History

  1. Publication Status: New
  2. Published Online: 3 JUL 2013

SEARCH